Michael Charles France

Aegis Surgical Ltd. develops healthcare equipment for the treatment of symptomatic aortic stenosis. The company was founded by William N. Starling Jr. and is headquartered in Dublin, Ireland.

BaroSense Inc. operates as a medical device company that focuses on the research and development of minimally invasive medical devices for the treatment of obesity. The company was founded by Richard S. Stack and William N. Starling, Jr. in 2001 and is headquartered in Redwood City, CA.

i360medical Ltd. provides healthcare and medical device solutions. It offers medical device companies, SMEs and entrepreneurs the opportunity to have specialist clinicians and medical device engineers collaboratively validate their devices and assist them with their clinical investigation and commercialization needs across six development stages. The company was founded by Derek Young in 2012 and is headquartered in Dublin, Ireland.

Yor Labs, Inc. offers an ultraportable-handheld device for diagnostic care. The company is headquartered in Portland, OR.

Aqua Medical, Inc. develops disruptive, vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and prevent GI cancers. The company was founded by Virender K. Sharma and is headquartered in Santa Ana, CA.

Synergy Life Science Partners LP invests in companies located in the United States. The fund targets companies operating in the fields of medical device and drugs. It provides financing for early stage capital requirements.

Conveyor Cardiovascular Ltd. is an Irish company that engages in research and development of natural sciences. The company is based in Dublin, Ireland. The CEO of the company is William N. Starling.

SonoVascular, Inc. provides endovascular treatment services. The company is based in Chapel Hill, NC. The CEO of the company is Daniel E. Estay.

Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA.

FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium.

InnAVasc Medical, Inc. designs and develops products for vascular access for hemodialysis. Its technology vascular access graft is designed to create one contiguous flow lumen without transition points. The company is headquartered in Durham, NC.

Cardiac Pathways Corp. designs, develops and manufactures cardiac diagnosis systems. Its products consist principally of systems for performing ablation treatment and for diagnostic mapping. Cardiac Pathways is located in Sunnyvale, CA.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Synecor LLC (Synecor) is a venture capital firm founded in 2000 by Richard S. Stack, William N. Starling, and Judith L. Swain. The firm is headquartered in Chapel Hill, North Carolina.

NC IDEA (Venture Capital) is a Venture Capital firm, a subsidiary of NC IDEA founded in 1900. The firm is headquartered in Durham, North Carolina.

Synergy Management Company I LLC (Synergy Management Company) is a venture capital firm founded in 2006 by Richard S. Stack, William N. Starling and John Onopchenko. The firm is headquartered in San Francisco, California.

IDEA Fund Partners LLC (IDEA Fund Partners) is a venture capital firm founded in 2007 by David P. Rizzo, John Cambier and Lister Delgado. The firm is headquartered in Durham, North Carolina.

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Interventional Autonomics Corp. supplies pharmaceutical products. The American company was founded in 2008 by William N. Starling.

Atrius Health, Inc. provides healthcare services. It offers a variety of programs for patients with asthma, heart disease, diabetes, AIDS, and cancer. Its services include CT scan, endoscopy, mammography, and weight management. The company was founded in 1969 and is headquartered in Newton, MA.

Part of Medtronic Plc, Novacor, Inc. is an American company that develops artificial heart and related technologies. The company is based in CA. Novacor was acquired by World Heart Corp., a subsidiary of Medtronic Plc from Edwards Lifesciences Corp. on June 30, 2000 for $58 million.

Part of NeuroTronik, Inc., Neurotronik Ltd. is an Irish company that manufactures medical and surgical equipment as well as orthopedic appliances. The company is based in Dublin, Ireland. The company was founded by William N. Starling.

Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA.

415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany.